Literature DB >> 6839548

IgA1 half molecules in human multiple myeloma and the in vitro production of similar fragments from intact IgA1 molecules.

J Biewenga, E Van Loghem.   

Abstract

This paper describes an IgA related protein Vla which occurred in the serum and urine of a patient with multiple myeloma. The protein was isolated from urine; it had a molecular mass of 70,000 daltons. It was shown to be a two chain IgA half molecule, consisting of a deleted alpha heavy chain, with a molecular mass of 42,000 daltons, which was disulphide linked to a normal kappa type light chain. Fabc fragments were produced from an unrelated myeloma IgA. These had the same biochemical properties as protein V1a, except for the absence of the disulphide linkage between the deleted heavy chains and the light chains. Protein Vla and the Fabc fragments could both be cleaved by IgA1 protease from Streptococcus sanguis, which indicates the presence of the alpha 1 hinge region. An inventory of its antigenic determinants and their similarity to those of previously characterized F(abc)2 fragments, indicates that protein Vla, like the Fabc fragments, contains the CH1 and CH2 domains, but lacks most of the CH3 domain. The fact that cleavage by IgA1 protease from S. sanguis yields a Fab fragment but fails to yield a CH2 domain demonstrates that cleavage by the enzyme is not only restricted to the Pro227-Thr228 bond in the IgA1 hinge region.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6839548      PMCID: PMC1536886     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  Enzymatic fragmentation of human IgA F(abc)'2: a new peptic fragment.

Authors:  C Rivat; J Bourguignon; M Fontaine; C Ropartz
Journal:  Immunochemistry       Date:  1977-01

2.  Structural studies on a human IgA1 myeloma protein with a carboxy-terminal deletion.

Authors:  J P Despont; C A Abel; H M Grey; G M Penn
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

3.  The synthesis and assembly of immunoglobulins by malignant human plasmacytes. 3. Heterogeneity in IgA polymer assembly.

Authors:  J N Buxbaum; S Zolla; M D Scharff; E C Franklin
Journal:  Eur J Immunol       Date:  1974-05       Impact factor: 5.532

4.  Differential sensitivity of IgA proteins of different subclasses and allotypes to reduction of disulfide bonds and digestion by streptococcal protease.

Authors:  G Virella; J Koistinen; R Cardenas; C C Patrick; T B Higerd; J W Fett; H H Fudenberg
Journal:  Immunochemistry       Date:  1978-03

5.  Studies on Fd-fragments of human immunoglobulins. II. The preparation and characterization of peptic (Fab')2-fragments and an Fd'-fragment of IgA-myeloma proteins.

Authors:  B J Zegers; J J van der Sluis; R E Ballieux
Journal:  Biochim Biophys Acta       Date:  1974-06-07

6.  Messenger RNA coding for the deleted heavy chain of mouse myeloma MOPC 47A immunoglobulin.

Authors:  E A Robinson; U Ferrini; J G Seidman; E Appella
Journal:  J Biol Chem       Date:  1980-06-10       Impact factor: 5.157

7.  Human IgA1 half-molecules: clinical and immunologic features in a patient with multiple myeloma.

Authors:  I Sakurabayashi; K Kin; T Kawai
Journal:  Blood       Date:  1979-02       Impact factor: 22.113

8.  Human myeloma IgA half-molecules.

Authors:  H L Spiegelberg; B G Fishkin
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

9.  Complete amino acid sequence of the alpha 2 heavy chain of a human IgA2 immunoglobulin of the A2m (2) allotype.

Authors:  A Toraño; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

10.  Differential susceptibility of human IgA immunoglobulins to streptococcal IgA protease.

Authors:  A G Plaut; R Wistar; J D Capra
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

View more
  2 in total

1.  A paraprotein IgA1 occurring in serum, urine, and cerebrospinal fluid (CSF): immunochemical and idiotypic evidence of synthesis in situ by the central nervous system (CNS).

Authors:  F Bollengier; A Mahler; A Gillard; E Wijffels
Journal:  J Clin Immunol       Date:  1986-07       Impact factor: 8.317

2.  Production and characterization of pepsin fragments of human IgA1 to determine domain-specificity of monoclonal anti-IgA antibodies.

Authors:  J Biewenga; A Faber; J C Pronk; J J Haaijman
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.